Author:
Provenzani Riccardo,San-Martin-Galindo Paola,Hassan Ghada,Legehar Ashenafi,Kallio Aleksi,Xhaard Henri,Fallarero Adyary,Yli-Kauhaluoma Jari
Abstract
AbstractBiofilms are multicellular communities of microorganisms that generally attach to surfaces in a self-produced matrix. Unlike planktonic cells, biofilms can withstand conventional antibiotics, causing significant challenges in the healthcare system. Currently, new chemical entities are urgently needed to develop novel anti-biofilm agents. In this study, we designed and synthesized a set of 2,4,5,6-tetrasubstituted pyrimidines and assessed their antibacterial activity against planktonic cells and biofilms formed by Staphylococcus aureus. Compounds 9e, 10d, and 10e displayed potent activity for inhibiting the onset of biofilm formation as well as for killing pre-formed biofilms of S. aureus ATCC 25923 and Newman strains, with half-maximal inhibitory concentration (IC50) values ranging from 11.6 to 62.0 µM. These pyrimidines, at 100 µM, not only decreased the number of viable bacteria within the pre-formed biofilm by 2–3 log10 but also reduced the amount of total biomass by 30–50%. Furthermore, these compounds were effective against planktonic cells with minimum inhibitory concentration (MIC) values lower than 60 µM for both staphylococcal strains. Compound 10d inhibited the growth of S. aureus ATCC 25923 in a concentration-dependent manner and displayed a bactericidal anti-staphylococcal activity. Taken together, our study highlights the value of multisubstituted pyrimidines to develop novel anti-biofilm agents.
Funder
Strategic Research Council at the Academy of Finland
Finnish Cultural Foundation
Jane and Aatos Erkko Foundation
Academy of Finland
Helsingin Yliopisto
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations (2016). https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf .
2. Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. Pharm. Ther. 40, 277–283 (2015).
3. Rossolini, G. M., Arena, F., Pecile, P. & Pollini, S. Update on the antibiotic resistance crisis. Curr. Opin. Pharmacol. 18, 56–60. https://doi.org/10.1016/j.coph.2014.09.006 (2014).
4. Bryers, J. D. Medical biofilms. Biotechnol. Bioeng. 100, 1–18. https://doi.org/10.1002/bit.21838 (2008).
5. Romling, U. & Balsalobre, C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med. 272, 541–561. https://doi.org/10.1111/joim.12004 (2012).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献